Login

Antony Mattessich, President & CEO, Ocular Therapeutix 00:00:00

Share On Facebook Share On Twitter

Ocular Therapeutix

Recent Videos

00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
00:10:00
James Anderson: Guanajuato Silver Expands with $50M Bolanitos Deal, Building Mexico’s Fastest-Growing Silver Producer|James Anderson,CHAIRMAN & CEO,Guanajuato Silver Company Ltd
00:10:00
Highland Copper Company Targets 2026 Construction Decision as Fully Permitted Copperwood Project Gains U.S. Federal Financing Momentum|Barry O’Shea,CEO,Highland Copper

Suggestions

00:10:00
Interview with Chesapeake Gold Corp's Interim CEO John Paulos at the 1-2-1 Mining Investment New York Event.
00:10:00
Bitcoin 2022: Jon Wilk, CEO of CompoSecure, on Fintech Leadership and Arculus | Jon Wilk - CEO of CompoSecure
00:10:00
Private Equity Veteran on Founding Trop Capital and a Unique Investment Approach
00:10:00
Invests in early-stage investments in technology companies with conviction since 1970|Devdutt Yellurkar,General Partner,CRV
00:10:00
Radiopharmaceutical Innovations in Cancer Diagnosis |Dr Alan Taylor , Executive Chairma, Clarity Pharmaceuticals Ltd.
00:10:00
Community Concerned Over Jackson National Life Expansion Impact
00:10:00
Strong Quarter for Yes Bank: Profit Surges 38% as Provisions Decline | Mike Dunbar, CEO , Mamba Exploration.
00:10:00
Challenges and Opportunities in Today's Investment Landscape | Abel Sithole, CEO , Public Investment Corporation.
00:00:00
Skinbiotherapeutics get set for live data trial to target skin conditions including psoriasis - Stuart Ashman Chief Executive, Skinbiotherapeutics
00:10:00
Interview with Avesoro: Advancing Exploration and Development at the One-to-One Mining Investment Conference in New York
00:10:00
Don Baxter on Focus Graphite's Unique Production Method and Rising Demand from Tesla
00:10:00
SiTime CEO Rajesh Vashist states that 85% of their customers are single-source.

© 2017 - Neuhu+